Pharmaceuticals

China Human Respiratory Syncytial Virus Drugs Market Research Report 2017

  • QYR1043768
  • 119 Pages
  • March 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Human Respiratory Syncytial Virus Drugs

Revenue, means the sales value of Human Respiratory Syncytial Virus Drugs

This report studies Human Respiratory Syncytial Virus Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

AstraZeneca

AbbVie

GSK

Teva Pharmaceutical

Ablynx

ADMA Biologics

Alnylam Pharmaceuticals

Ark Biosciences

Aviragen Therapeutics

Bavarian Nordic

Boehringer Ingelheim

Gilead Sciences

ImmunoVaccine Technologies

Johnson & Johnson

Kyowa Hakko Kirin

Medivir, Mucosis

Mymetics

Novavax

Regeneron Pharmaceuticals

ReViral

Vaxart

Market Segment by Regions (provinces), covering

South China

East China

Southwest China

Northeast China

North China

Central China

Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

Approved Drugs

Off-Label Drugs

Split by Application, this report focuses on consumption, market share and growth rate of Human Respiratory Syncytial Virus Drugs in each application, can be divided into

Hospitals

Clinics

Table of Contents

China Human Respiratory Syncytial Virus Drugs Market Research Report 2017

1 Human Respiratory Syncytial Virus Drugs Market Overview

1.1 Product Overview and Scope of Human Respiratory Syncytial Virus Drugs

1.2 Human Respiratory Syncytial Virus Drugs Segment by Type

1.2.1 China Production Market Share of Human Respiratory Syncytial Virus Drugs Type in 2015

1.2.2 Approved Drugs

1.2.3 Off-Label Drugs

1.3 Applications of Human Respiratory Syncytial Virus Drugs

1.3.1 Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015

1.3.2 Hospitals

1.3.3 Clinics

1.4 China Market Size (Value) of Human Respiratory Syncytial Virus Drugs (2012-2022)

1.5 China Human Respiratory Syncytial Virus Drugs Status and Outlook

1.6 Government Policies

2 China Human Respiratory Syncytial Virus Drugs Market Competition by Manufacturers

2.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Human Respiratory Syncytial Virus Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Human Respiratory Syncytial Virus Drugs Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Human Respiratory Syncytial Virus Drugs Manufacturing Base Distribution, Sales Area, Product Type

2.5 Human Respiratory Syncytial Virus Drugs Market Competitive Situation and Trends

2.5.1 Human Respiratory Syncytial Virus Drugs Market Concentration Rate

2.5.2 Human Respiratory Syncytial Virus Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Human Respiratory Syncytial Virus Drugs Manufacturers Profiles/Analysis

3.1 AstraZeneca

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.1.2.1 Product A

3.1.2.2 Product B

3.1.3 AstraZeneca Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 AbbVie

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.2.2.1 Product A

3.2.2.2 Product B

3.2.3 AbbVie Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 GSK

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.3.2.1 Product A

3.3.2.2 Product B

3.3.3 GSK Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 Teva Pharmaceutical

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.4.2.1 Product A

3.4.2.2 Product B

3.4.3 Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Ablynx

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.5.2.1 Product A

3.5.2.2 Product B

3.5.3 Ablynx Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 ADMA Biologics

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.6.2.1 Product A

3.6.2.2 Product B

3.6.3 ADMA Biologics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 Alnylam Pharmaceuticals

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.7.2.1 Product A

3.7.2.2 Product B

3.7.3 Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Ark Biosciences

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.8.2.1 Product A

3.8.2.2 Product B

3.8.3 Ark Biosciences Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Aviragen Therapeutics

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.9.2.1 Product A

3.9.2.2 Product B

3.9.3 Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 Bavarian Nordic

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Human Respiratory Syncytial Virus Drugs Product Type, Application and Specification

3.10.2.1 Product A

3.10.2.2 Product B

3.10.3 Bavarian Nordic Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 Boehringer Ingelheim

3.12 Gilead Sciences

3.13 ImmunoVaccine Technologies

3.14 Johnson & Johnson

3.15 Kyowa Hakko Kirin

3.16 Medivir, Mucosis

3.17 Mymetics

3.18 Novavax

3.19 Regeneron Pharmaceuticals

3.20 ReViral

3.21 Vaxart

4 China Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)

4.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth (2012-2017)

4.2 China Human Respiratory Syncytial Virus Drugs Revenue and Growth (2012-2017)

4.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

5 China Human Respiratory Syncytial Virus Drugs Production, Revenue (Value), Price Trend by Type

5.1 China Human Respiratory Syncytial Virus Drugs Production and Market Share by Type (2012-2017)

5.2 China Human Respiratory Syncytial Virus Drugs Revenue and Market Share by Type (2012-2017)

5.3 China Human Respiratory Syncytial Virus Drugs Price by Type (2012-2017)

5.4 China Human Respiratory Syncytial Virus Drugs Production Growth by Type (2012-2017)

6 China Human Respiratory Syncytial Virus Drugs Market Analysis by Application

6.1 China Human Respiratory Syncytial Virus Drugs Consumption and Market Share by Application (2012-2017)

6.2 China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 ChinaHuman Respiratory Syncytial Virus Drugs Market Analysis by Regions (Provinces)

7.1 China Human Respiratory Syncytial Virus Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)

7.1.1 China Human Respiratory Syncytial Virus Drugs Production and Market Share by Regions (Provinces)(2012-2017)

7.1.2 China Human Respiratory Syncytial Virus Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)

7.1.3 China Human Respiratory Syncytial Virus Drugs Sales Price by Regions (Provinces)(2012-2017)

7.2 China Human Respiratory Syncytial Virus Drugs Consumption by Regions (Provinces)(2012-2017)

7.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

8 Human Respiratory Syncytial Virus Drugs Manufacturing Cost Analysis

8.1 Human Respiratory Syncytial Virus Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 China Human Respiratory Syncytial Virus Drugs Market Forecast (2017-2022)

12.1 China Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue Forecast (2017-2022)

12.2 China Human Respiratory Syncytial Virus Drugs Production, Import, Export and Consumption Forecast (2017-2022)

12.3 China Human Respiratory Syncytial Virus Drugs Production Forecast by Type (2017-2022)

12.4 China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Application (2017-2022)

12.5 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.5.1 China Human Respiratory Syncytial Virus Drugs Production Forecast by Regions (Provinces)(2017-2022)

12.5.2 China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Regions (Provinces)(2017-2022)

12.5.3 China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

12.6 Human Respiratory Syncytial Virus Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Human Respiratory Syncytial Virus Drugs

Figure China Production Market Share of Human Respiratory Syncytial Virus Drugs by Type in 2015

Figure Product Picture of Approved Drugs

Table Major Manufacturers of Approved Drugs

Figure Product Picture of Off-Label Drugs

Table Major Manufacturers of Off-Label Drugs

Table Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015

Figure Hospitals Examples

Figure Clinics Examples

Figure China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Table China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers (2015 and 2016)

Table China Human Respiratory Syncytial Virus Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers in 2015

Figure China Human Respiratory Syncytial Virus Drugs Capacity of Key Manufacturers in 2016

Table China Human Respiratory Syncytial Virus Drugs Production of Key Manufacturers (2015 and 2016)

Table China Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers (2015 and 2016)

Figure 2015 Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers

Figure 2016 Human Respiratory Syncytial Virus Drugs Production Share by Manufacturers

Table China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers

Table 2016 China Human Respiratory Syncytial Virus Drugs Revenue Share by Manufacturers

Table China Market Human Respiratory Syncytial Virus Drugs Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Human Respiratory Syncytial Virus Drugs Average Price of Key Manufacturers in 2015

Table Manufacturers Human Respiratory Syncytial Virus Drugs Manufacturing Base Distribution and Sales Area

Table Manufacturers Human Respiratory Syncytial Virus Drugs Product Type

Figure Human Respiratory Syncytial Virus Drugs Market Share of Top 3 Manufacturers

Figure Human Respiratory Syncytial Virus Drugs Market Share of Top 5 Manufacturers

Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AstraZeneca Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure AstraZeneca Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AbbVie Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure AbbVie Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GSK Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure GSK Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Teva Pharmaceutical Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table Ablynx Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Ablynx Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Ablynx Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table ADMA Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ADMA Biologics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure ADMA Biologics Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Alnylam Pharmaceuticals Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table Ark Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Ark Biosciences Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Ark Biosciences Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table Aviragen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Aviragen Therapeutics Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bavarian Nordic Human Respiratory Syncytial Virus Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

Figure Bavarian Nordic Human Respiratory Syncytial Virus Drugs Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ImmunoVaccine Technologies Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Medivir, Mucosis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mymetics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ReViral Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Vaxart Basic Information, Manufacturing Base, Sales Area and Its Competitors

Figure China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth (2012-2017)

Figure China Human Respiratory Syncytial Virus Drugs Revenue (Million USD) and Growth (2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production by Type (2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production Share by Type (2012-2017)

Figure Production Market Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)

Figure 2015 Production Market Share of Human Respiratory Syncytial Virus Drugs by Type

Table China Human Respiratory Syncytial Virus Drugs Revenue by Type (2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Human Respiratory Syncytial Virus Drugs by Type (2012-2017)

Figure 2015 Revenue Market Share of Human Respiratory Syncytial Virus Drugs by Type

Table China Human Respiratory Syncytial Virus Drugs Price by Type (2012-2017)

Figure China Human Respiratory Syncytial Virus Drugs Production Growth by Type (2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Consumption by Application (2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application (2012-2017)

Figure China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Application in 2015

Table China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)

Figure China Human Respiratory Syncytial Virus Drugs Consumption Growth Rate by Application (2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production by Regions (Provinces)(2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production Market Share by Regions (Provinces)(2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production Value by Regions (Provinces)(2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production Value Market Share by Regions (Provinces)(2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Sales Price by Regions (Provinces)(2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Consumption by Regions (Provinces)(2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Consumption Market Share by Regions (Provinces)(2012-2017)

Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Export and Import (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Human Respiratory Syncytial Virus Drugs

Figure Manufacturing Process Analysis of Human Respiratory Syncytial Virus Drugs

Figure Human Respiratory Syncytial Virus Drugs Industrial Chain Analysis

Table Raw Materials Sources of Human Respiratory Syncytial Virus Drugs Major Manufacturers in 2015

Table Major Buyers of Human Respiratory Syncytial Virus Drugs

Table Distributors/Traders List

Figure China Human Respiratory Syncytial Virus Drugs Capacity, Production and Growth Rate Forecast (2017-2022)

Figure China Human Respiratory Syncytial Virus Drugs Revenue and Growth Rate Forecast (2017-2022)

Table China Human Respiratory Syncytial Virus Drugs Production, Import, Export and Consumption Forecast (2017-2022)

Table China Human Respiratory Syncytial Virus Drugs Production Forecast by Type (2017-2022)

Table China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Application (2017-2022)

Table China Human Respiratory Syncytial Virus Drugs Production Forecast by Regions (Provinces)(2017-2022)

Table China Human Respiratory Syncytial Virus Drugs Consumption Forecast by Regions (Provinces)(2017-2022)

Table China Human Respiratory Syncytial Virus Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370